Response

Affiliations

¹ Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences and Medicine, Faculty of Health and Medicine, Hunter Medical Research Institute and the University of Newcastle, Newcastle, NSW, Australia.
² Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences and Medicine, Faculty of Health and Medicine, Hunter Medical Research Institute and the University of Newcastle, Newcastle, NSW, Australia. Electronic address: paul.foster@newcastle.edu.au.

Comment

Gabriela A Hoefel et al. Chest. 2020 Aug.

. 2020 Aug;158(2):828-829.

doi: 10.1016/j.chest.2020.03.044.

¹ Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences and Medicine, Faculty of Health and Medicine, Hunter Medical Research Institute and the University of Newcastle, Newcastle, NSW, Australia.
² Priority Research Centre for Healthy Lungs, Department of Microbiology and Immunology, School of Biomedical Sciences and Medicine, Faculty of Health and Medicine, Hunter Medical Research Institute and the University of Newcastle, Newcastle, NSW, Australia. Electronic address: paul.foster@newcastle.edu.au.

No abstract available

Comment on

MicroRNAs in Lung Diseases.
Hoefel G, Tay H, Foster P. Hoefel G, et al. Chest. 2019 Nov;156(5):991-1000. doi: 10.1016/j.chest.2019.06.008. Epub 2019 Jun 27. Chest. 2019. PMID: 31255581 Review.
MicroRNAs in Lung Disease: A Focus on Sarcoidosis.
Pattnaik B, Madan K, Mohan A, Mittal S. Pattnaik B, et al. Chest. 2020 Aug;158(2):828. doi: 10.1016/j.chest.2020.01.057. Chest. 2020. PMID: 32768067 No abstract available.